On October 6, 2021, leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar covered advanced concepts of toxicity management and risk factors drawing from recommendations within the Clinical Practice Guideline (CPG). The recorded webinar and presentation slides are available below.
Webinar Faculty:
The webinar discussed the use of ICI treatments in cases involving:
Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org, or check out our free CPG mobile app.
The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/15/2021). The SITC Clinical Practice Guidelines are produced by SITC and have no funding from outside sources.
Meeting: SITC Clinical Practice Guideline Webinar — Case Studies in Immune Checkpoint Inhibitor-related Adverse Events; Faculty: Julie R. Brahmer, MD, MSc – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Laura Cappelli, MD, MHS, MS – Johns Hopkins University; Marc S. Ernstoff, MD – National Institutes of Health; Mario Lacouture, MD – Memorial Sloan Kettering Cancer Center; Bianca D. Santomasso, MD, PhD – Memorial Sloan Kettering Cancer Center; Date: October 6, 202100:55:34
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us